Sam Rainsy

RMC Group Plc produces and supplies construction materials. The company's products include building blocks and horizontal load-bearing beams. It is subsidiary of Cemex UK Ltd. RMC Group was founded in 1930 by Kjeld Ammentorp and is headquartered in Egham, UK.

Lazard & Co. Ltd. provides investment banking services. The company offers its services for corporations, partnerships, institutions, governments and high-net worth individuals. The company operates in approximately 29 cities in key business and financial centers across 16 countries in Europe, North America, Asia, Australia and South America. The company is located in London, UK.

123ID, Inc. develops biometric software solutions. It provides pattern analysis and matching of fingerprints based on vector field principles. The company also provides products to work in practical applications, addressing the realities of identifying persons under live conditions. 123ID was founded in May, 2002 and is headquartered in Labsdowne, VA.

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA.

Part of Centrica Plc, GB Gas Holdings Ltd. is an international energy services and British solutions company. The company is based in Windsor, UK. The company's parent company, Centrica Plc, is the parent company of British Gas, Centrica Hive, Bord Gais, Centrica Business Solutions, and Centrica Storage. The company was founded in 1996.

INTELLIKEY Corp. manufactures an electronic key access control system. Its products include slim line controller, standard controller, intelligent keys and gate locks. The company is headquartered in Melbourne, FL.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

NatWest Markets Plc engages in the provision of banking and financial services. It operates through the NatWest Markets and Central Items and Other segments. The NatWest Markets segment offers trading, risk management, and financing solutions. The Central Items and Other segment includes corporate functions and other activity of the firm. The company was founded on October 31, 1984 and is headquartered in London, the United Kingdom.

EuroUS Ventures Management LLC (EuroUS Ventures Management) is a venture capital firm founded in 2005 by Lucian Wagner. The firm is headquartered in San Francisco, California.

Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts.

Bolster Investment Partners BV (Bolster Investment Partners) is an independent private equity firm. The firm was founded by Mark van Rijn, Joost Bakhuizen, Michiel van Wissen and Paul Vogelzang in 1982. The firm is headquartered in Amsterdam, the Netherlands.

Attolight AG manufactures edge cathodoluminescence instruments to measure carrier dynamics in nanostructures. It also distributes electron microscopes. The company was founded by Samuel Sonderegger and Jean Berney in 2008 and is headquartered in Ecublens, Switzerland.

UK Financial Investments Ltd. is a bank recapitalisation fund and acts as a bank holding company for government-owned banks. The company is based in London, UK and ultimately controlled by the Government of United Kingdom.

Part of Centrica Plc, British Gas Ltd. is a company that supplies gas and electricity, boilers and boiler covers. The company is based in Windsor, UK.

Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia.

Bodygee AG provides photorealistic 3D body scanning, measurement, and tracking solutions for the fitness, health, and beauty industries. Bodygee is based in Bern, CH and was founded in 2015 by Marcel Frikart, who has been the CEO since then. The Swiss company specializes in the acquisition, analysis, and 3D visualization of body data. Bodygee Orbiter, a 3D turntable body scanner, is designed for boutiques and personal training studios, offering high accuracy and a great user experience. The company's solutions, including Orbiter and Boxx, enable fitness businesses to convert customers into members and generate additional revenue.

TTfactor SRL develops oncology research, technology advancement and intellectual property transfer programs. It operates as a technology transfer and market connection company focused on the advancement of scientific results through technology licensing, sponsored research, clinical trials, drug discovery, and molecular medicine programs. The company was founded by Daniela Bellomo in 2010 and is headquartered in Milan, Italy.